Study of effects of clinical and genetic factors on severity of discirculatory encephalopathy with the help of pattern recognition methods
Matematičeskaâ biologiâ i bioinformatika, Tome 6 (2011) no. 1, pp. 115-146.

Voir la notice de l'article provenant de la source Math-Net.Ru

The paper presents the results of studies aimed to assess effects of clinical, biochemical indices and also polymorphous variants of genes coding angiotensin-converting enzyme (ACE), lipoprotein lipase (LPL) and cholesteryl ester transfer protein (CETP) on discirculatory encephalopathy (DEP) severity. Methods of intellectual data analysis based on searching optimal partitions of feature space and different pattern recognition techniques were used during the research. It was found that statistically valid relationship exists between computer estimates of DEP severity that are calculated by set of clinical and biochemical parameters with the help of pattern recognition techniques and polymorphous variants of genes coding APF and CETP.
@article{MBB_2011_6_1_a10,
     author = {A. V. Kuznetsova and I. V. Kostomarova and N. N. Vodolagina and N. A. Malygina and O. V. Senko},
     title = {Study of effects of clinical and genetic factors on severity of discirculatory encephalopathy with the help of pattern recognition methods},
     journal = {Matemati\v{c}eska\^a biologi\^a i bioinformatika},
     pages = {115--146},
     publisher = {mathdoc},
     volume = {6},
     number = {1},
     year = {2011},
     language = {ru},
     url = {http://geodesic.mathdoc.fr/item/MBB_2011_6_1_a10/}
}
TY  - JOUR
AU  - A. V. Kuznetsova
AU  - I. V. Kostomarova
AU  - N. N. Vodolagina
AU  - N. A. Malygina
AU  - O. V. Senko
TI  - Study of effects of clinical and genetic factors on severity of discirculatory encephalopathy with the help of pattern recognition methods
JO  - Matematičeskaâ biologiâ i bioinformatika
PY  - 2011
SP  - 115
EP  - 146
VL  - 6
IS  - 1
PB  - mathdoc
UR  - http://geodesic.mathdoc.fr/item/MBB_2011_6_1_a10/
LA  - ru
ID  - MBB_2011_6_1_a10
ER  - 
%0 Journal Article
%A A. V. Kuznetsova
%A I. V. Kostomarova
%A N. N. Vodolagina
%A N. A. Malygina
%A O. V. Senko
%T Study of effects of clinical and genetic factors on severity of discirculatory encephalopathy with the help of pattern recognition methods
%J Matematičeskaâ biologiâ i bioinformatika
%D 2011
%P 115-146
%V 6
%N 1
%I mathdoc
%U http://geodesic.mathdoc.fr/item/MBB_2011_6_1_a10/
%G ru
%F MBB_2011_6_1_a10
A. V. Kuznetsova; I. V. Kostomarova; N. N. Vodolagina; N. A. Malygina; O. V. Senko. Study of effects of clinical and genetic factors on severity of discirculatory encephalopathy with the help of pattern recognition methods. Matematičeskaâ biologiâ i bioinformatika, Tome 6 (2011) no. 1, pp. 115-146. http://geodesic.mathdoc.fr/item/MBB_2011_6_1_a10/

[1] Skvortsova V. I., Limborskaya S. A., Koltsova E. A., Slominskii P. A., Nevrologiya i psikhiatriya, Prilozhenie “Insult”, 1 (2001), 23–29

[2] Gusev E. I., Martynov M. Yu., Yasamanova A. N. i dr., “Etiologicheskie faktory i faktory riska sosudistoi mozgovoi nedostatochnosti i mozgovogo insulta”, Nevrologiya i psikhiatriya, Prilozhenie “Insult”, 1 (2001), 41–46

[3] Federalnaya sluzhba gosudarstvennoi statistiki, 2009 http://www.gks.ru

[4] Maksudov G. A., “Distsirkulyatornaya entsefalopatiya”, Sosudistye zabolevaniya nervnoi sistemy, ed. Shmidt E. V., Meditsina, M., 1975, 501–512

[5] Mancia G., “Prevention and treatment of stroke in patients with hypertension”, Clin. Ther., 26:5 (2004), 631–648 | DOI

[6] Clifford C. P., Nunez D. J. R., “Racial differences in the frequency of the restriction site polymorphism of the angiotensin converting enzyme (ACE) gene”, Abstracts 16th Sci. Meeting Internat. Soc. Hypertension (Glasgow, UK, 1996), Abstract 4B.2.0736

[7] Rigat B., Hubert C., Corvol P. et al., “PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1)”, Nucl. Acids Res., 20 (1991), 1433 | DOI

[8] Skvortsova V. I., Limborskaya S. A., Koltsova E. A., Slominskii P. A., Shetova I. M., Botsina A. Yu., Shamalov N. A., Nevrologiya i psikhiatriya, 3 (2002), 47–51

[9] Rosei E. A., “Hypertension, atherosclerosis and LVH in ELSA”, Blood Pressure, 5:4 (1996), 44–47

[10] Ahn Y. I., Kamboh M. I., Hamman R. F. et al., “Two DNA polymorphism in lipoprotein lipase gene and there associations with factors related to cardiovascular disease”, J. Lipid Res., 34 (1993), 421–428

[11] Sparkes R. S., Zollman S., Klisak I. et. al., “Human genes involved in lipolys of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21”, Genomics, 1 (1987), 138–144 | DOI

[12] OMIM – On-line Mendelian Inheritance in Man http://www.ncbi.nlm.nih.gov/omim

[13] Chamberlain J. C., Thorn J. A., Morgan R. et al., “Genetic variation at the lipoprotein lipase gene associated with coronary atherosclerosis”, Adv. Exp. Med. Biol., 285 (1990), 275–281

[14] Mattu R. K., Needham E. W., Morgan R., Rees A., Hackshaw A. K., Stocks J., Elwood P. C., Galton D. J., “DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population”, Arteriosclerosis and Thrombosis, 14:7 (1994), 1090–1097 | DOI

[15] Gambino R., Scaglione L., Alemanno N., Pagano G., Cassader M., “Human lipoprotein lipase HindIII polymorphism in young patients with myocardial infarction”, Metabolism, 48:9 (1999), 1157–1161 | DOI

[16] Kostomarova I. V., Vodolagina N. N., Malygina N. A. i dr., “Svyaz polimorfizma genov lipoproteinlipazy i belka-perenoschika efirov kholesterina s prodolzhitelnostyu zhizni bolnykh s khronicheskoi ishemiei mozga”, Klinicheskaya meditsina, 2008, no. 4, 22–28

[17] Zhuravlëv Yu. I., Ryazanov V. V., Senko O. V., Raspoznavanie. Matematicheskie metody. Programmnaya sistema. Primeneniya, Fazis, Moskva, 2006

[18] Zhuravlëv Yu. I., “Ob algebraicheskom podkhode k resheniyu zadach raspoznavaniya ili klassifikatsii”, Problemy kibernetiki, 33, Nauka, M., 1978, 5–68

[19] Kuznetsova A. V., Senko O. V., “Vozmozhnosti ispolzovaniya metodov Data Mining v mediko-laboratornykh issledovaniyakh dlya vyyavleniya zakonomernostei v massivakh dannykh”, Vrach i informatsionnye tekhnologii, 2005, no. 1, 49–56

[20] Senko O. V., Kuznetsova A. V., The Optimal Valid Partitioning Procedures, “InterStat”, Statistics in Internet http://interstat.statjournals.net/YEAR/2006/abstracts/0604002.php?Name=604002

[21] Gordon D. J., “High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies”, Circulation, 79 (1989), 8–15 | DOI

[22] Oganov R. G., Shalnova S. A., Kalinina A. M., Profilaktika serdechno-sosudistykh zabolevanii, M., 2009, 216 pp.

[23] Franklin S. S., Larson M. G., Khan S. A. et al., “The Framingham Heart Study”, Circulation, 103:9 (2001), 1245–1249

[24] Kannel W. P., Wolf P. A. et al., “Risk stratification in hypertension: new insights from the Framingham Study”, Am. J. Hypertens, 13:1, suppl. 1 (2000), S3–S10 | DOI

[25] Chazova E. I., Smetnik V. P. i dr., Sistemnye gipertenzii, 2008, no. 3, 27–29